SanBio Company Limited (TSE: 4592)
Health Care · Biotechnology · JP
¥1,001.00
-1.77% today · -63.1% 1Y
SanBio Company Limited (TSE: 4592) operates in the Biotechnology industry within the Health Care sector. The company is valued at $494.90M and employs 33 people.
Over the last twelve months the share price has lost 63.1%, trading between 858.00 and 3.49K.
Tweenvest scores SanBio Company Limited across four factors: quality 38/100, value 49/100. Its strongest factor is value.
4592 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $494.90M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -47.70
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- ¥3,490.00
- 52-week low
- ¥858.00
- Avg volume (3M)
- —
- Shares outstanding
- 78.06M
- Employees
- 33
- Next earnings
- —
About SanBio Company Limited
SanBio Company Limited is dedicated to the creation, production, and sale of regenerative cell therapies, primarily concentrated on disorders of the central nervous system. A central component of their portfolio is SB623, a treatment that has completed Phase 2 clinical trials in both the United States and Japan for traumatic brain injury. Beyond this, their comprehensive research pipeline explores the broader potential of SB623 for conditions such as ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, and Alzheimer's disease. The company's development efforts also encompass other innovative treatments: SB618 for peripheral nerve damage, SB308 for muscular dystrophy, MSC1 for cancer, and MSC2 for inflammatory diseases and optic neuritis. Founded in 2001, SanBio maintains its corporate headquarters in Tokyo, Japan.
- ISIN
- JP3336750009
- Founded
- 2001
- Listed since
- Apr 8, 2015
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Crescent Biopharma, Inc.NasdaqCM: CBIO | $506.76M | $11.84 | -20.59% |
| Jiangsu Sihuan Bioengineering Co., LtdSZSE: 000518 | $506.22M | CN¥3.29 | -8.61% |
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $504.77M | CN¥31.21 | -10.50% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $496.25M | CN¥5.06 | -11.69% |
| Pharmicell Co., Ltd.KOSE: A005690 | $489.67M | ₩10,880.00 | -15.40% |
| Ever Supreme Bio Technology Co., LtdTPEX: 6712 | $487.43M | NT$157.00 | -2.79% |
| Neurogene Inc.NasdaqGM: NGNE | $485.88M | $24.28 | -6.90% |
| Faeth Therapeutics, Inc.NasdaqCM: FTH | $485.80M | $18.80 | -27.78% |
Figures last refreshed Oct 18, 2026.